Clinical Trial

The Medacta International AMIStem-P Post-Marketing Surveillance Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a Post-Market Surveillance study of AMIStem-P femoral stem prosthesis
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-08-04; most recent amendment 2025-05-05.
Status change: Recruiting → Active, Not Recruiting 2022-12-05
Trial Details
NCT Number NCT04997005
Lead Sponsor Medacta International SA
Conditions Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis, Congenital Hip Dysplasia, Avascular Necrosis of the Femoral Head
Enrollment 550 participants
Start Date 2019-04-26
Primary Completion 2029-04-30 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-08